Global Wearable Injector Market - Forecasts from 2019 to 2024
The global wearable injectors market is anticipated to grow at a CAGR of 39.10% during the forecast period. Wearable injectors are also called patch pumps or patch injectors are the devices used for delivery of drugs. The device helps to deliver the drugs in a controlled manner which is faster and safer through subcutaneous tissues. Wearable injectors are user friendly and they reduce the need of multiple painful injections making it convenient for the patients. The growth of the market may be attributed to the increase in incidence of cancer and diabetes, and adoption of advanced technological products. Favourable reimbursement scenario in developed countries pertaining to wearable injectors will also augment the growth of the market during the forecast period. However, preference and availability of alternative drug delivery modes might hamper the growth of the market during the given time frame.
The Global Wearable Injectors Market – Forecasts from 2019 to 2024 is an exhaustive study which aims to present the key market trends through various chapters focusing on different aspects of the market. The study provides a detailed market overview through the market dynamics sections which detail key market, drivers, restraints, and opportunities in the current market. The report analyzes key opportunity regional markets, and the current technology penetration through lifecycle analysis. The report also analyzes the market through comprehensive market segmentation by type, component, platform and geography.
The global wearable injectors market has been segmented based on type, application, end-user, and geography. Based on type, the market has been segmented into on body and off body. By application, the market has been segmented into oncology, cardiovascular diseases, diabetes, and others. By end-users, the market has been classified as hospitals and clinics, ambulatory surgery centers, and home care centers.
Regional analysis has been provided with detailed analysis and forecast for the period 2018 to 2024. The global market has been broken down into North America, South America, Europe, Middle East and Africa (MEA), and the Asia Pacific regions. The report also analyzes 15 countries across these regions with thorough analysis and forecast along with prevailing market trends and opportunities which each of these countries present for the manufacturers.
Major players in the global wearable injectors market have been covered along with their relative competitive position and strategies. The report also mentions recent deals and investments of different market players over the last year. The company profiles section details the business overview, financial performance for the past three years, key products and services being offered along with the recent developments of these important players in the global wearable injectors market.
Segmentation:
The Global Wearable Injectors Market – Forecasts from 2019 to 2024 is an exhaustive study which aims to present the key market trends through various chapters focusing on different aspects of the market. The study provides a detailed market overview through the market dynamics sections which detail key market, drivers, restraints, and opportunities in the current market. The report analyzes key opportunity regional markets, and the current technology penetration through lifecycle analysis. The report also analyzes the market through comprehensive market segmentation by type, component, platform and geography.
The global wearable injectors market has been segmented based on type, application, end-user, and geography. Based on type, the market has been segmented into on body and off body. By application, the market has been segmented into oncology, cardiovascular diseases, diabetes, and others. By end-users, the market has been classified as hospitals and clinics, ambulatory surgery centers, and home care centers.
Regional analysis has been provided with detailed analysis and forecast for the period 2018 to 2024. The global market has been broken down into North America, South America, Europe, Middle East and Africa (MEA), and the Asia Pacific regions. The report also analyzes 15 countries across these regions with thorough analysis and forecast along with prevailing market trends and opportunities which each of these countries present for the manufacturers.
Major players in the global wearable injectors market have been covered along with their relative competitive position and strategies. The report also mentions recent deals and investments of different market players over the last year. The company profiles section details the business overview, financial performance for the past three years, key products and services being offered along with the recent developments of these important players in the global wearable injectors market.
Segmentation:
- By Type
- On Body
- Off Body
- By Application
- Oncology
- Cardiovascular Diseases
- Diabetes
- Others
- By End-User
- Hospitals and Clinics
- Ambulatory Surgery Centres
- Home Care Centers
- By Geography
- North America
- USA
- Canada
- Mexico
- South America
- Brazil
- Argentina
- Others
- Europe
- United Kingdom
- Germany
- France
- Spain
- Others
- Middle East and Africa
- Saudi Arabia
- Israel
- Others
- Asia Pacific
- China
- Japan
- India
- South Korea
- Others
1. INTRODUCTION
1.1. Market Overview
1.2. Market Definition
1.3. Scope of the Study
1.4. Currency
1.5. Assumptions
1.6. Base, And Forecast Years Timeline
2. RESEARCH METHODOLOGY
2.1. Research Design
2.2. Secondary Sources
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
4.1. Market Segmentation
4.2. Market Drivers
4.3. Market Restraints
4.4. Market Opportunities
4.5. Porter’s Five Forces Analysis
4.5.1. Bargaining Power of Suppliers
4.5.2. Bargaining Power of Buyers
4.5.3. Threat of New Entrants
4.5.4. Threat of Substitutes
4.5.5. Competitive Rivalry in the Industry
4.6. Life Cycle Analysis - Regional Snapshot
4.7. Market Attractiveness
5. GLOBAL WEARABLE INJECTORS MARKET BY TYPE
5.1. On body
5.2. Off body
6. GLOBAL WEARABLE INJECTORS MARKET BY APPLICATION
6.1. Oncology
6.2. Cardiovascular Diseases
6.3. Diabetes
6.4. Others
7. GLOBAL WEARABLE INJECTORS MARKET BY END-USER
7.1. Hospitals and Clinics
7.2. Ambulatory Surgery Centres
7.3. Home Care Centres
8. GLOBAL WEARABLE INJECTORS MARKET BY GEOGRAPHY
8.1. North America
8.1.1. USA
8.1.2. Canada
8.1.3. Mexico
8.2. South America
8.2.1. Brazil
8.2.2. Argentina
8.2.3. Others
8.3. Europe
8.3.1. Germany
8.3.2. United Kingdom
8.3.3. France
8.3.4. Spain
8.3.5. Others
8.4. Middle East and Africa
8.4.1. Saudi Arabia
8.4.2. Israel
8.4.3. Others
8.5. Asia Pacific
8.5.1. China
8.5.2. Japan
8.5.3. India
8.5.4. South Korea
8.5.5. Others
9. COMPETITIVE INTELLIGENCE
9.1. Competitive Benchmarking and Analysis
9.2. Strategies of Key Players
9.3. Recent Investments and Deals
10. COMPANY PROFILES
10.1. Becton, Dickinson and Company (BD)
10.2. Subcuject Aps
10.3. Enable Injections
10.4. YPSOMED
10.5. E3D Elcam Drug Delivery Devices
10.6. Insulet Corporation
10.7. Medtronic
10.8. Valeritas, Inc.
10.9. Amgen
1.1. Market Overview
1.2. Market Definition
1.3. Scope of the Study
1.4. Currency
1.5. Assumptions
1.6. Base, And Forecast Years Timeline
2. RESEARCH METHODOLOGY
2.1. Research Design
2.2. Secondary Sources
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
4.1. Market Segmentation
4.2. Market Drivers
4.3. Market Restraints
4.4. Market Opportunities
4.5. Porter’s Five Forces Analysis
4.5.1. Bargaining Power of Suppliers
4.5.2. Bargaining Power of Buyers
4.5.3. Threat of New Entrants
4.5.4. Threat of Substitutes
4.5.5. Competitive Rivalry in the Industry
4.6. Life Cycle Analysis - Regional Snapshot
4.7. Market Attractiveness
5. GLOBAL WEARABLE INJECTORS MARKET BY TYPE
5.1. On body
5.2. Off body
6. GLOBAL WEARABLE INJECTORS MARKET BY APPLICATION
6.1. Oncology
6.2. Cardiovascular Diseases
6.3. Diabetes
6.4. Others
7. GLOBAL WEARABLE INJECTORS MARKET BY END-USER
7.1. Hospitals and Clinics
7.2. Ambulatory Surgery Centres
7.3. Home Care Centres
8. GLOBAL WEARABLE INJECTORS MARKET BY GEOGRAPHY
8.1. North America
8.1.1. USA
8.1.2. Canada
8.1.3. Mexico
8.2. South America
8.2.1. Brazil
8.2.2. Argentina
8.2.3. Others
8.3. Europe
8.3.1. Germany
8.3.2. United Kingdom
8.3.3. France
8.3.4. Spain
8.3.5. Others
8.4. Middle East and Africa
8.4.1. Saudi Arabia
8.4.2. Israel
8.4.3. Others
8.5. Asia Pacific
8.5.1. China
8.5.2. Japan
8.5.3. India
8.5.4. South Korea
8.5.5. Others
9. COMPETITIVE INTELLIGENCE
9.1. Competitive Benchmarking and Analysis
9.2. Strategies of Key Players
9.3. Recent Investments and Deals
10. COMPANY PROFILES
10.1. Becton, Dickinson and Company (BD)
10.2. Subcuject Aps
10.3. Enable Injections
10.4. YPSOMED
10.5. E3D Elcam Drug Delivery Devices
10.6. Insulet Corporation
10.7. Medtronic
10.8. Valeritas, Inc.
10.9. Amgen
